#savethejointTM

PRP HA - Cellular Matrix

Complimentary HA and A-PRP Therapy

Synergistically combines the complementary clinical effects of PRP and HA to provide added benefit for OA patients

A-PRP: The patient’s platelet concentrate prepared with Cellular Matrix, provides an autologous reservoir of growth factors.

CellularMatrix A-CP-HA - Medical Device Class III - CE2797

Cellular Matrix is a cell-friendly network that contains 2ml of HA at a concentration of 20mg/ml (40mg total), in addition to the thixotropic cell-separation gel and the sodium citrate anticoagulant solution.

Hyaluronic Acid (HA) is a major component of synovial fluid contributing to joint homeostasis.

  • 25 years of clinical experience show pain relief and functional improvement lasting 6-12 months
  • Plays a major role in viscosupplementation and pain relief in OA
  • A network of HA chains constitutes an ideal cell-friendly matrix

Intended use of the device:

  • Device used to prepare intra-articular injections into the knee for symptomatic treatment of articular pain and mobility improvement.Device used to prepare intra-dermal injections for hydration of dehydrated and wrinkled skin tissues.

Contra indications:

  • Do not administer to patients with ascertained hypersensitivity to one of the components, or suffering from serious disease such as cancer or infection in joint or in the treated area. The administration of the HA/PRP preparation to patients suffering from inflammatory joint diseases and autoimmune diseases such as rheumatoid arthritis or Bechterew disease is not recommended. The administration to children, pregnant or lactating women is not recommended.

#savethejointTM

 

PRP HA - Cellular Matrix

#savethejointTM


COMPLEMENTARY HA AND A-PRP THERAPY

Synergistically combines the complementary clinical effects of PRP and HA to provide added benefit for OA patients

A-PRP: The patient’s platelet concentrate prepared with Cellular Matrix, provides an autologous reservoir of growth factors.

CellularMatrix A-CP-HA - Medical Device Class III - CE2797

Cellular Matrix is a cell-friendly network that contains 2ml of HA at a concentration of 20mg/ml (40mg total), in addition to the thixotropic cell-separation gel and the sodium citrate anticoagulant solution.

Hyaluronic Acid (HA) is a major component of synovial fluid contributing to joint homeostasis.

  • 25 years of clinical experience show pain relief and functional improvement lasting 6-12 months
  • Plays a major role in viscosupplementation and pain relief in OA
  • A network of HA chains constitutes an ideal cell-friendly matrix
Intended use of device

CellularMatrix A-CP HA

Intended use of the device: 

Device used to prepare intra-articular injections into the knee for symptomatic treatment of articular pain and mobility improvement.Device used to prepare intra-dermal injections for hydration of dehydrated and wrinkled skin tissues.

Contra-indications

CONTRA-INDICATIONS:

Do not administer to patients with ascertained hypersensitivity to one of the components, or suffering from serious disease such as cancer or infection in joint or in the treated area. The administration of the HA/PRP preparation to patients suffering from inflammatory joint diseases and autoimmune diseases such as rheumatoid arthritis or Bechterew disease is not recommended. The administration to children, pregnant or lactating women is not recommended.

FOR ANY PRODUCT INFORMATION YOU REQUIRE

More information


Company

JOINT OPERATIONS (UK) LLP
Unit 11 Interface Business Park
Bincknoll Lane
Royal Wootton Bassett
Wiltshire
SN4 8SY
UK

Company no. OC396027
VAT no. GB 198327955

Contact

OFFICE HOURS:

Mon - Fri 08:30 to 17:30
Tel. +44 (0) 1793 575 050

OUT OF HOURS BURNS SUPPORT:

Tel. +44 (0)1793 575 041

Joint Operations Helping innovators in their work...

© 2020 Joint Operations Ltd
website development .: Clockwork
Joint Operations is a ISO 9001:2005 registered company
Joint Operations is a ISO 9001:2005 registered company

Helping innovators in their work...

Joint Operations is a ISO 9001:2005 registered company
© 2020 Joint Operations Ltd
website development .: Clockwork